Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurofeedback-Based Digital Therapeutics for ADHD in Children
NCT06369714Recruiting
- Start
- Feb 2023
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms). Primary endpoint: Swanson, Nolan, and Pelham IV Rating Scale at 32 weeks. Started Feb 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06369714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06369714.